Photo of Timo Otonkoski
  • PL 63 (Haartmaninkatu 8), C507b

    HELSINGIN YLIOPISTO

    Finland

  • PL 63 (Haartmaninkatu 8)

    00014

    Finland

  • Finland

1996 …2022
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • 311 Basic medicine
  • pluripotent stem cell
  • diabetes
  • pancreatic beta cell
  • 1184 Genetics, developmental biology, physiology
  • 3111 Biomedicine

International and National Collaboration Publications and projects within past five years.

Publications 1996 2019

Copy number variation and selection during reprogramming to pluripotency

Hussein, S. M., Batada, N. N., Vuoristo, S., Ching, R. W., Autio, R., Narva, E., Ng, S., Sourour, M., Hämäläinen, R., Olsson, C., Lundin, K., Mikkola, M., Trokovic, R., Peitz, M., Bruestle, O., Bazett-Jones, D. P., Alitalo, K., Lahesmaa, R., Nagy, A. & Otonkoski, T., 2011, In : Nature. 471, 7336, p. 58-62 7 p.

Research output: Contribution to journalArticleScientificpeer-review

Concise Review: Human Pluripotent Stem Cells for the Modeling of Pancreatic beta-Cell Pathology

Balboa, D., Saarimaki-Vire, J. & Otonkoski, T., Jan 2019, In : Stem Cells. 37, 1, p. 33-41 9 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

MANF is Required for the Postnatal Expansion and Maintenance of the Pancreatic β-Cell Mass in Mice

Danilova, T., Belevich, I., Li, H., Palm, E., Jokitalo, E., Otonkoski, T. & Lindahl, M., Jan 2019, In : Diabetes. 68, 1, p. 66-80 15 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy

Haikala, H. M., Anttila, J. M., Marques, E., Raatikainen, T., Ilander, M., Hakanen, H., Ala-Hongisto, H., Savelius, M., Balboa, D., Von Eyss, B., Eskelinen, V., Munne, P., Nieminen, A. I., Otonkoski, T., Schüler, J., Laajala, T. D., Aittokallio, T., Sihto, H., Mattson, J., Heikkilä, P. & 7 othersLeidenius, M., Joensuu, H., Mustjoki, S., Kovanen, P., Eilers, M., Leverson, J. D. & Klefström, J., 6 Feb 2019, In : Nature Communications. 10, 17 p., 620.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Human pluripotent reprogramming with CRISPR activators

Weltner, J., Balboa, D., Katayama, S., Bespalov, M., Krjutskov, K., Jouhilahti, E-M., Trokovic, R., Kere, J. & Otonkoski, T., 6 Jul 2018, In : Nature Communications. 9, 12 p., 2643.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Projects 2006 2022

Prizes

Novo Nordisk Foundation Lecture Award

Timo Otonkoski (Recipient), 9 May 2014

Prize: Prizes and awards

Ray and Robert L. Kroc Lecture Award

Timo Otonkoski (Recipient), 11 Jun 2009

Prize: Prizes and awards

Activities 1998 2016

European Society for Pediatric Endocrinology Annual Meeting 2012

Timo Otonkoski (Speaker: Keynote)
22 Sep 201225 Sep 2012

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

Hazem Ibrahim

Timo Pyry Juhani Otonkoski (Host)
Feb 2016 → …

Activity: Hosting a visitor typesAcademic visit at UH

Mariia Cherepkova

Timo Pyry Juhani Otonkoski (Host)
Feb 2016Mar 2016

Activity: Hosting a visitor typesAcademic visit at UH

Mariia Cherepkova

Timo Pyry Juhani Otonkoski (Host)
Jun 2016May 2017

Activity: Hosting a visitor typesAcademic visit at UH

Beta-cell dysfunction: Lessons from stem cells

Timo Otonkoski (Speaker)
14 Sep 2016

Activity: Talk or presentation typesInvited talk

Press / Media

Inhimillinen tekijä, YLE TV2

Timo Otonkoski

19/10/2004

1 media contribution

Press/Media: Press / Media

PRISMA, YLE TV1

Timo Otonkoski

29/09/2004

1 media contribution

Press/Media: Press / Media

TV-ohjelma (TV-nytt)

Timo Otonkoski

01/06/2000

1 media contribution

Press/Media: Press / Media

Prisma-phjelma /Yle TV1

Timo Otonkoski

01/01/2000

1 media contribution

Press/Media: Press / Media

Equipment